Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kura Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.013 Good day, everyone. My name is Lenius, and I will be your conference operator today. 00:00:05.013 -- 00:00:10.374 At this time, I would like to welcome you to the Cura Oncology second quarter 2026 financial 00:00:10.374 -- 00:00:16.096 results earnings call. All lines have been placed on mute to prevent any background noise. 00:00:16.096 -- 00:00:19.657 After the speaker's remarks, there will be a question and answer session. 00:00:19.657 -- 00:00:23.878 If you would like to ask a question during this time, and if you've joined via the webinar, 00:00:23.878 -- 00:00:29.271 please use the raise hand icon, which can be found at the bottom of your webinar application. 00:00:29.271 -- 00:00:33.734 To allow everyone the opportunity to participate, we ask that you please limit yourself 00:00:33.734 -- 00:00:37.296 to one question and one follow-up question. 00:00:37.296 -- 00:00:41.538 If time permits, at the end of the Q&A session, we invite you to rejoin the queue for 00:00:41.538 -- 00:00:43.640 additional questions. 00:00:43.640 -- 00:00:48.182 At this time, I would like to turn the call over to Greg Mann, Senior Vice President 00:00:48.182 -- 00:00:52.005 of Investor Relations and Corporate Affairs of Cura Oncology. 00:00:52.005 -- 00:00:54.425 Please go ahead. 00:00:54.490 -- 00:00:59.332 Thank you, Linnaeus. Good afternoon and welcome to Cura Oncology's second quarter 2026 00:00:59.332 -- 00:01:02.534 conference call. Joining the call today are Dr. 00:01:02.534 -- 00:01:07.916 Troy Wilson, President and Chief Executive Officer, Brian Powl, Chief Commercial Officer, 00:01:07.916 -- 00:01:12.959 Dr. Mollie Leoni, Chief Medical Officer, and Tom Doyle, Senior Vice President, Finance 00:01:12.959 -- 00:01:14.672 and Accounting. 00:01:1...